Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(25%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_2
4
50%
Ph early_phase_1
1
13%
Ph phase_1
2
25%
Ph not_applicable
1
13%

Phase Distribution

3

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
4(50.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 12 (25.0%)
Phase 24 (50.0%)
N/A1 (12.5%)

Trials by Status

completed675%
active_not_recruiting113%
recruiting113%

Recent Activity

2 active trials
Showing 5 of 8
recruitingphase_2

Acute Equol Supplementation and Vascular Function in Women With and Without CKD

NCT06128278
active_not_recruitingphase_2

Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers

NCT05741060
completednot_applicable

A Nutritional Supplement on Vasomotor Symptoms in Women

NCT04516304
completedearly_phase_1

S-equol in Women With Triple Negative Breast Cancer

NCT02352025
completedphase_2

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

NCT00962390
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06128278Phase 2

Acute Equol Supplementation and Vascular Function in Women With and Without CKD

Recruiting
NCT05741060Phase 2

Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers

Active Not Recruiting
NCT04516304Not Applicable

A Nutritional Supplement on Vasomotor Symptoms in Women

Completed
NCT02352025Early Phase 1

S-equol in Women With Triple Negative Breast Cancer

Completed
NCT00962390Phase 2

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

Completed
NCT00962585Phase 2

Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients

Completed
NCT00998920Phase 1

Multi-Dose Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers

Completed
NCT00787007Phase 1

Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8